A new entry to carbocyclic nucleosides: Oxidative coupling reaction of cycloalkenylsilanes with a nucleobase mediated by hypervalent iodine reagent

Organic Letters

Volumn 10, Issue 16, 2008, Pages 3449-3452

  Yoshimura, Yuichi ^a   Ohta, Masatoshi ^a   Imahori, Tatsushi ^a   Imamichi, Tomozumi ^b   Takahata, Hiroki ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CYTIDINE; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; IODINE; NUCLEOSIDE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SILANE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; OXIDATION REDUCTION REACTION; STEREOISOMERISM; SYNTHESIS;

ANTI-HIV AGENTS; CYTIDINE; INDICATORS AND REAGENTS; IODINE; MOLECULAR STRUCTURE; NUCLEOSIDES; OXIDATION-REDUCTION; PURINES; PYRIMIDINES; SILANES; STEREOISOMERISM;

EID: 54049122291     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol8012155     Document Type: Article

References (18)

1. Vince, R.; Hua, M. J. Med. Chem. 1990, 33, 17.
2. Song, G. Y.; Paul, V.; Choo, H.; Morrey, J.; Sidwell, R. W.; Schinazi, R. F.; Chu, C. K. J. Med. Chem. 2001, 44, 3985.
3. Katagiri, N.; Shiraishi, T.; Sato, H.; Toyota, A.; Kaneko, C.; Yusa, K.; Oh-hara, T.; Tsuruno, T. Biochem. Biophys. Res. Commun. 1992, 184, 154.
4. Wang, J.; Froeyen, M.; Hendrix, C.; Andrei, G.; Snoeck, R.; De Clercq, E.; Herdewijn, P. J. Med. Chem. 2000, 43, 736.
5. (a) Yamada, K.; Sakata, S.; Yoshimura, Y. J. Org. Chem. 1998, 63, 6891.
6. (b) Yoshimura, Y.; Asami, K.; Matsui, H.; Tanaka, H.; Takahata, H. Org. Lett. 2006, 8, 6015.
7. (c) Yoshimura, Y.; Yamazaki, Y.; Kawahata, M.; Yamaguchi, K.; Takahata, H. Tetrahedron Lett. 2007, 48, 4519.
8. Typically, Mitsunobu reaction and Pd-catalyzed cross-coupling reaction have been used:(a) Barral, K.; Halfon, P.; Pèpe, G.; Camplo, M. Tetrahedron Lett. 2002, 43, 81.
9. (b) Trost, B. M.; Li, L.; Guile, S. D. J. Am. Chem. Soc. 1992, 114, 8745.
10. (a) Ochiai, M.; Fujita, E.; Arimoto, M.; Yamaguchi, H. Chem. Pharm. Bull. 1985, 33, 41.
11. (b) Dohi, T.; Maruyama, A.; Minamitsuji, Y.; Takenaga, N.; Kita, Y. Chem. Commun. 2007, 1224.
12. (c) Dohi, T.; Morimoto, K.; Takenaga, N.; Goto, A.; Maruyama, A.; Kiyono, Y.; Tohma, H.; Kita, Y. J. Org. Chem. 2007, 72, 109.
13. Kira, M.; Hino, T.; Sakurai, H. Tetrahedron Lett. 1989, 30, 1099.
14. Hayashi, T.; Han, J. W.; Takeda, A.; Tang, J.; Nohmi, K.; Mukaide, K.; Tsuji, H.; Uozumi, Y. Adv. Synth. Catal. 2001, 343, 279.
15. The synthesis of the purine derivatives of 10a has been reported: Rosenquist, Å; Kvarnström, I.; Classon, B.; Samuelsson, B. J. Org. Chem. 1996, 61, 6382. Although those were reported to be inactive against HIV, the anti-HIV activitiy of the pyrimidine derivatives has not been investigated. Additionally, 10c,d were considered to be a new class of carbocyclic nucleosides.
16. Jung, M. E.; Gaede, B. Tetrahedron 1979, 35, 621.
17. Sekine, M.; Matsuzaki, J.; Satoh, M.; Hata, T. J. Org. Chem. 1982, 47, 571.
18. Anti-HIV-1 activities of the compounds were evaluated by suppression of HIV replication in PBMCs by p24 antigen capture assay.